Clinical Trials Search

Title Intervention Sponsor Status
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Quality-of-Life Assessment, Questionnaire Administration, Placebo Administration National Cancer Institute (NCI) Active, not recruiting
VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue Vitamin D and fish oil placebo, Vitamin D and fish oil, Fish oil and vitamin D placebo, Vitamin D placebo and fish oil placebo Brigham and Women's Hospital Active, not recruiting
MRI Based Active Selection for Treatment Trial Multi-Parametric MRI, MRI-Guided Biopsy University of Miami Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib National Cancer Institute (NCI) Active, not recruiting
Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention omega 3 fatty acids City of Hope Medical Center Active, not recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer Endocrine therapy interruption ETOP IBCSG Partners Foundation Active, not recruiting
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Magnetic Resonance Imaging, Therapeutic Conventional Surgery, Therapeutic Surgical Procedure, Radiation Therapy, Endocrine Therapy, Quality-of-Life Assessment, Laboratory Biomarker Analysis, Cytology Specimen Collection Procedure ECOG-ACRIN Cancer Research Group Active, not recruiting
ASPirin Intervention for the REDuction of Colorectal Cancer Risk Placebo for Aspirin, Aspirin Massachusetts General Hospital Active, not recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration National Cancer Institute (NCI) Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine National Cancer Institute (NCI) Active, not recruiting